When a medication is helping patients, but you can’t give it to everyone who needs it, what comes next?
With the surge of drugs like GLP-1s, physicians and health systems are asked to balance high-quality, value-based care against the financial realities of specialty medications.
Join this free, live webinar to learn about:
- How preventive care can help with rising drug costs
- The role biosimilars could play
- What GLP-1s reveal about the future of accessible care
Can't watch live? Register now and we’ll send you the recording afterward.
